NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT03935893 2025-07-10Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersUniversity of PittsburghPhase 2 Recruiting240 enrolled
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled